Subscribe

One email a week: new science briefs plus China out-licensing, NewCo and clinical-data briefs, each with a source link. Free; unsubscribe any time.

Sign up

To subscribe, email contact@inlightbio.com with the subject “Subscribe” and we will add you to the weekly list.

Prefer a feed? Use RSS.

What you get

  • New science briefs: recent papers and preprints, with study design, key numbers and a DOI link.
  • New China out-licensing and NewCo deals, with upfront and milestones separated.
  • Clinical readouts that change the value of China-originated assets.
  • Upcoming partnering and investor meetings.

Working on a NewCo? That goes to bd@inlightbio.com, not the newsletter address.